International Women in Engineering Day
General
Adjuvants: Possible Key to COVID-19 Vaccines
The Latest From Avanti
Type 1 Diabetes Preceded by Pro-Inflammatory Lipids in Children
Using Metabolomics to Find a SARS-CoV-2 Biomarker
cGMP and GMP: What’s the Difference?
Leading Research from the European Journal of Lipid Science and Technology
The Best Way to Kill COVID-19 Is Simpler Than You Might Think
Research Spotlight: New Technologies Shed Light on Caveolae
Exciting new functions for the small (50-100 nm) cellular invaginations, known as caveolae, are being understood!
How Can We Help?
For 50 years, we have made it our mission to provide research and pharmaceutical scientists with the highest purity products. We offer solutions for the entire product cycle-Research to Commercialization. We are dedicated to providing excellent customer service every step of the way! Whether searching for products, placing an order, or taking advantage of our custom synthesis service, please reach out to us during any part of the ordering process. We are here to help!
147th Edition of the Avanti Newsletter
Whether you are looking for phospholipids, sphingolipids, sterols, or any other of our numerous product offerings, Avanti’s research products are the highest purity lipids on the market and give you the best possibility for success.
NEW products this week: 10/17/2017
Deuterated Hydroxy Phytosphingosine (S & R), Deuterated Hydroxy Ceramide (S & R), Deuterated Hydroxy Sphinganine (S & R), Deuterated Phytosphingosine. Deuterated Hydroxy Sphingosine...
This week in research: March 29, 2017
Researchers from Northwest University (Xi’an, Shaanxi, China) used numerous lipid analytical standards from Avanti in a serum lipidomic analysis using UPLC-QTOF/HDMS to study lipid metabolism in chronic kidney disease (CKD). This interesting work identifies profound changes in lipid metabolites in individuals with CKD...
This week in research: April 5, 2017
People do Amazing Things with Our Lipids! Researchers from the National Center for Global Health and Medicine (Tokyo, Japan) are studying the role of PAF signaling in neuropathic pain, a chronic pain condition resulting from injury of the peripheral or central nervous systems. PAF, as well as, ATP and lyophosphatidic acid are thought to be central mediators of neuropathic pain.